⌘K
Loading ticker…
Genelux Corporation Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Genelux Corporation Common Stock (GNLX) has a 3-month relative strength percentile of 56 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 45. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.7%, relative volume 2.02×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
56 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
GNLX is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $3M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $3M |
| VXFVanguard Extended Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GNLX Jan avg: -0.74% median: -15.68% win: 25% σ: 47.27% n: 4 2023-01-27 → 2026-05-29 | GNLX Feb avg: 36.62% median: 8.93% win: 75% σ: 84.18% n: 4 2023-01-27 → 2026-05-29 | GNLX Mar avg: 5.11% median: -15.35% win: 25% σ: 55.18% n: 4 2023-01-27 → 2026-05-29 | GNLX Apr avg: -13.62% median: -6.58% win: 25% σ: 27.05% n: 4 2023-01-27 → 2026-05-29 | GNLX May avg: 0.94% median: 1.20% win: 50% σ: 14.38% n: 4 2023-01-27 → 2026-05-29 | GNLX Jun avg: 3.62% median: 18.59% win: 67% σ: 27.43% n: 3 2023-01-27 → 2026-05-29 (current) | GNLX Jul avg: -5.83% median: 0.00% win: 67% σ: 27.33% n: 3 2023-01-27 → 2026-05-29 | GNLX Aug avg: 8.09% median: 11.28% win: 67% σ: 8.71% n: 3 2023-01-27 → 2026-05-29 | GNLX Sep avg: 12.21% median: 9.22% win: 100% σ: 12.69% n: 3 2023-01-27 → 2026-05-29 | GNLX Oct avg: 29.17% median: 35.87% win: 67% σ: 66.82% n: 3 2023-01-27 → 2026-05-29 | GNLX Nov avg: -21.88% median: -17.99% win: 0% σ: 8.10% n: 3 2023-01-27 → 2026-05-29 | GNLX Dec avg: -5.37% median: -12.27% win: 33% σ: 20.54% n: 3 2023-01-27 → 2026-05-29 |